These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16146782)

  • 1. Signal transduction in CD4+CD25+ regulatory T cells: CD25 and IL-2.
    Thornton AM
    Front Biosci; 2006 Jan; 11():921-7. PubMed ID: 16146782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential role for STAT5 signaling in CD25+CD4+ regulatory T cell homeostasis and the maintenance of self-tolerance.
    Antov A; Yang L; Vig M; Baltimore D; Van Parijs L
    J Immunol; 2003 Oct; 171(7):3435-41. PubMed ID: 14500638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of T-cell activation by CD4+ CD25+ suppressor T cells.
    Shevach EM; McHugh RS; Piccirillo CA; Thornton AM
    Immunol Rev; 2001 Aug; 182():58-67. PubMed ID: 11722623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells.
    Bayer AL; Yu A; Malek TR
    J Immunol; 2007 Apr; 178(7):4062-71. PubMed ID: 17371960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2.
    Antony PA; Restifo NP
    J Immunother; 2005; 28(2):120-8. PubMed ID: 15725955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-beta and CD4+CD25+ regulatory T cells.
    Huber S; Schramm C
    Front Biosci; 2006 Jan; 11():1014-23. PubMed ID: 16146793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
    Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
    J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontogeny, function, and peripheral homeostasis of regulatory T cells in the absence of interleukin-7.
    Peffault de Latour R; Dujardin HC; Mishellany F; Burlen-Defranoux O; Zuber J; Marques R; Di Santo J; Cumano A; Vieira P; Bandeira A
    Blood; 2006 Oct; 108(7):2300-6. PubMed ID: 16763207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion.
    Curotto de Lafaille MA; Lino AC; Kutchukhidze N; Lafaille JJ
    J Immunol; 2004 Dec; 173(12):7259-68. PubMed ID: 15585848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells and (CD4+)CD25+ T regulatory cells: crosstalk between two professionals in immunity versus tolerance.
    Chen W
    Front Biosci; 2006 May; 11():1360-70. PubMed ID: 16368522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective availability of IL-2 is a major determinant controlling the production of CD4+CD25+Foxp3+ T regulatory cells.
    Yu A; Malek TR
    J Immunol; 2006 Oct; 177(8):5115-21. PubMed ID: 17015695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2.
    Malek TR; Yu A; Vincek V; Scibelli P; Kong L
    Immunity; 2002 Aug; 17(2):167-78. PubMed ID: 12196288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells.
    Bensinger SJ; Walsh PT; Zhang J; Carroll M; Parsons R; Rathmell JC; Thompson CB; Burchill MA; Farrar MA; Turka LA
    J Immunol; 2004 May; 172(9):5287-96. PubMed ID: 15100267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-2 signaling and CD4+ CD25+ Foxp3+ regulatory T cells.
    Turka LA; Walsh PT
    Front Biosci; 2008 Jan; 13():1440-6. PubMed ID: 17981641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
    Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
    Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.
    Zheng SG; Wang JH; Gray JD; Soucier H; Horwitz DA
    J Immunol; 2004 May; 172(9):5213-21. PubMed ID: 15100259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective cell cycle induction by IL-2 in naive T-cells antigen stimulated in the presence of refractory T-lymphocytes.
    Inaba H; Geiger TL
    Int Immunol; 2006 Jul; 18(7):1043-54. PubMed ID: 16702166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4
    Hernandez R; LaPorte KM; Hsiung S; Santos Savio A; Malek TR
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34475132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple autoimmune-associated variants confer decreased IL-2R signaling in CD4+ CD25(hi) T cells of type 1 diabetic and multiple sclerosis patients.
    Cerosaletti K; Schneider A; Schwedhelm K; Frank I; Tatum M; Wei S; Whalen E; Greenbaum C; Kita M; Buckner J; Long SA
    PLoS One; 2013; 8(12):e83811. PubMed ID: 24376757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells.
    Moseman EA; Liang X; Dawson AJ; Panoskaltsis-Mortari A; Krieg AM; Liu YJ; Blazar BR; Chen W
    J Immunol; 2004 Oct; 173(7):4433-42. PubMed ID: 15383574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.